Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2017 / Jun / The ABCs of Autoimmunity
Microbiology & Immunology Microbiology and Immunology Cytology Infectious Disease

The ABCs of Autoimmunity

A unique type of B cell appears to play a role in the development of autoimmune disorders

By Michael Schubert 06/26/2017 1 min read

Share

“It’s well-known that autoimmune diseases mostly affect women – in fact, about 80 percent of all autoimmune patients are women,” explains Kira Rubtsova, a researcher and instructor in biomedical science at National Jewish Health. “At the same time, the onset of autoimmunity usually happens during adulthood.” Why are women so disproportionately affected by autoimmune issues? Rubtsova and her colleagues suspected that the female immune system undergoes changes with age that lead to the progression of autoimmunity – changes that the male immune system does not experience. But precisely what are those changes? In the quest to answer that question, Rubtsova’s research group discovered age-associated B cells (ABCs).

What are ABCs?
“ABCs are a unique subset of B cells that can be distinguished from other types by the expression of certain molecules. In particular, ABCs express the integrins CD11c and CD11b on their surfaces and contain high levels of transcription factor T-bet, none of which is expressed by other types of B cells.” And when the researchers compared the gene expression profiles of ABCs with those of other B cells, they found hundreds of differentially expressed genes – indicating that ABCs have a unique phenotype and likely a unique function (1).
What do ABCs do?
“ABCs are present at high frequency in lupus-prone mice,” says Rubtsova, “and their appearance coincides with the onset of the disease in these animals.” The team also observed elevated ABCs in human autoimmune disease patients – but at the time, they weren’t sure whether the appearance of ABCs caused the development of disease or merely coincided with it. In their recently published study (2), Rubtsova’s team generated mice that are predisposed to developing lupus-like autoimmunity, but lack T-bet expression in B cells (meaning that they cannot generate ABCs). “We have followed the health conditions of these mice over time, comparing them with lupus-prone mice that can develop ABCs,” she says. In the absence of ABCs, the lupus-prone mice were significantly less likely to develop disease. “These data led us to the conclusion that ABCs drive the onset of autoimmunity.”

Could ABCs be diagnostically useful?
“The presence of these cells can be used for diagnostic purposes,” Rubtsova says. It’s possible that, one day, patients suspected of autoimmune disorders could be tested for the presence of ABCs. And if the cells participate in the disease process, it’s also possible that people at risk of developing such disorders might even be screened using ABCs one day, allowing doctors to spot autoimmune diseases before symptoms arise. But Rubtsova also wants to highlight the therapeutic potential: “These cells can be used as targets for the development of novel therapies that could cure autoimmunity. Because our results indicate that ABCs represent the pathogenic subset of cells, their removal may lead to the amelioration of disease.” One of her team’s next goals is to develop a drug capable of depleting or inactivating ABCs. In the meantime, many questions remain. How do ABCs promote the development of autoimmunity? Why is T-bet expression so critical for the development of these cells? And why are females more predisposed to developing ABCs and autoimmune diseases?

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. K Rubtsova et al., “Age-associated B cells: a T-bet-dependent effector with roles in protective and pathogenic immunity”, J Immunol, 195, 1933–1937 (2015). PMID: 26297793. K Rubtsova et al., “B cells expressing the transcription factor T-bet drive lupus-like autoimmunity”, J Clin Invest, 127, 1392–1404 (2017). PMID: 28240602.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.